Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 396 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Foot Ulcers, Diabetic Clear all

Conditions: Diabetic Foot Ulcers
Interventions: MEBO Wound Ointment, Standard of Care (sterile saline moistened gauze); Drug · Procedure
Lead sponsor: Skingenix, Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: New Haven, Connecticut • Boston, Massachusetts

Conditions: Complex Diabetic Foot Wounds
Interventions: Grafix®; Other
Lead sponsor: Osiris Therapeutics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 4
States / cities: Phoenix, Arizona • Tucson, Arizona • Miami, Florida + 1 more

Conditions: Diabetic Foot Ulcers
Interventions: FGF-1 141; Drug
Lead sponsor: Phage Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Wound; Foot, Wound Leg, Wound Heal, Diabetes Complications
Interventions: Remote wound monitoring technology; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes, Peripheral Neuropathy, Diabetic Foot, Diabetic Foot Ulcer
Interventions: Orpyx Sensory Insole System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetic Foot Ulcers, Diabetes
Interventions: Topical wound dressing, Human Amnion Allograft, usual wound care; Device · Biological · Other
Lead sponsor: University of North Dakota; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Diabetic Foot Ulcer
Interventions: gentamicin-collagen sponge, placebo collagen sponge; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Pasadena, Maryland

Conditions: Diabetic Foot Ulcer
Interventions: Therapist-Directed Re-loading; Behavioral
Lead sponsor: Mercer University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Venous Leg Ulcer, Venous Leg, Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Diabetic, Ulcer Foot, Leg Ulcer, Ulcer Venous, Ulcer
Interventions: ACApatch™, caregraFT™, Standard of Care; Other
Lead sponsor: Tiger Biosciences, LLC.; Industry
Eligibility: 21 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Diabetic Foot, DFU, Diabetic Foot Ulcer, Foot Ulcer, Diabetic, Ulcer Foot, Venous Leg Ulcer, Leg Ulcer, Leg Ulcers Venous, Ulcer
Interventions: Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU, Membrane Wrap-Lite™ DFU, Membrane Wrap-Hydro™ DFU, Standard of Care VLU, Tri-Membrane Wrap™ VLU, Membrane Wrap™ VLU, Membrane Wrap-Lite™ VLU, Membrane Wrap-Hydro™ VLU; Other
Lead sponsor: BioLab Holdings; Industry
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philidelphia, Pennsylvania

Conditions: Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer Due to Type 2 Diabetes Mellitus, Foot Ulcer, Diabetic, Foot Ulcer
Interventions: Standard of Care, EPIEFFECT, EPIXPRESS; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: Diabetic Foot Ulcer
Interventions: InnovaMatrix AC porcine placental ECM therapy; Device
Lead sponsor: ConvaTec Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 5
States / cities: North Port, Florida • Buffalo, New York • Monroeville, Pennsylvania + 2 more

Conditions: Diabetic Foot Ulcers (DFU), Venous Stasis Ulcers (VSU)
Interventions: OASIS Wound Matrix; Device
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 3
States / cities: Fort Smith, Arkansas • St Louis, Missouri • St. George, Utah

Conditions: Diabetic Feet
Interventions: Shoes with Rocker Soles; Device
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 40 Years to 60 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 1999
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer, Wound, Non-Healed
Interventions: DETEC® pH; Diagnostic Test
Lead sponsor: Progenitec Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Lake Success, New York • Arlington, Texas

Conditions: Acute and Chronic Wounds, Pressure Ulcers, Trauma Wounds, Diabetic Foot Ulcers, Venous Stasis Ulcers
Interventions: SNaP Wound Care System; Device
Lead sponsor: 3M; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Daly City, California

Conditions: Diabetes Mellitus, Healthy Volunteers
Interventions: Not listed
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years to 80 Years · Male only
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pressure Ulcer, Leg Ulcer, Diabetic Foot Ulcer
Interventions: ALLEVYN Life Non-Bordered, Standard Care; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Phoenix, Arizona • Martinez, California • Sylmar, California + 3 more

Conditions: Diabetic Foot Ulcer
Interventions: Dermal - Living Skin Replacement (Dermal - LSR); Device
Lead sponsor: ApoPharma; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 12
States / cities: Tuscon, Arizona • Mather, California • San Diego, California + 8 more

Conditions: Diabetic Foot
Interventions: Revita Allograft; Other
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Pensacola, Florida • Lake Charles, Louisiana • Springfield, Pennsylvania

Conditions: Non-healing Wound, Non-healing Diabetic Foot Ulcer, Diabetic Foot Infection
Interventions: TTAX01, Surgical resection and debridement, Systemic antibiotics, Off-loading; Biological · Procedure · Drug + 1 more
Lead sponsor: BioTissue Holdings, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 11
States / cities: Phoenix, Arizona • Sylmar, California • Miami, Florida + 8 more

Conditions: Chronic Limb Threatening Ischemia
Interventions: Transverse Tibial Bone Transport, TrueLok Elevate; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 95 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetic Foot Ulcers, Wound
Interventions: Topical Oxygen Chamber for Extremities; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Diabetic Foot Ulcer
Interventions: Omeza® Complete Matrix, Standard of Care; Device · Other
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 10
States / cities: Evergreen Park, Illinois • Denham Springs, Louisiana • Leesville, Louisiana + 7 more

Search by objective public record fields.

A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)

GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds

Safety Study of Topical Human FGF-1 for Wound Healing

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention

A Comparison of TCC-EZ Using Human Amnion Allograft vs TCC-EZ and Standard Wound Care in Treating Diabetic Foot Ulcers.

Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer

Self-directed Versus Therapist-directed Re-loading on Incidence of Ulcer Recurrence

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs

Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers

OASIS Wound Matrix (Oasis) Mechanism of Action

How Shoes With Rocker Soles Affect Walking

DETEC® pH Point of Care Wound Diagnostic Test

Clinical Evaluation of the SNaP Wound Care System

Impaired Wound Healing in Diabetic Foot Ulceration

Evaluation Of An Advanced Borderless Dressing

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

Topical Oxygen Therapy for Diabetic Wounds

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers